Rishabh Singh/X
Sep 18, 2025, 07:00
Rishabh Singh on NEJM Letter: FVIII Aurora Mutation Shows Increased Activity and Reduced APC Response
Rishabh Singh, an Heme/Onc fellow at Indiana University, posted on X:
“In a letter to the editor of NEJM, authors describe a naturally occurring FVIII variant, Arg590Ser (designated FVIII Aurora), with substantially increased activity and reduced responsiveness to activated protein C as compared with wild-type FVIII.”
Title: A Naturally Occurring Gain-of-Function Mutation in Factor VIII
Authors: Joshua T. Wischmeyer, Christine H. Baird, Julian Grandvallet Contreras, Alexander Tran, Tzu Phang, Tian Liu, Marilyn J. Manco-Johnson
Read the full version here.
Find similar posts on Hemostasis Today.
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies